Complement Serums

Work with confidence when you choose complement prepared by Pel-Freez: baby rabbit complement for vaccine development, guinea pig complement, and antibody-depleted human complement produced using a proprietary Pel-Freez separation process.

With a focus on delivering consistently-performing products, we tightly control and monitor every step of the production process in our ISO 9001-certified facility. But biological variability means that sometimes a specific lot doesn’t work for your application. When that happens, we work closely with you to make sure your project needs are met.

Complement Serums

Applications

Vaccine Development

Well known and widely used in the vaccine industry, Pel-Freez enables a range of safety and efficacy assays including:

  • Opsonophagocytic killing assays (OPKA)
  • Serum bactericidal assays (SBA)
  • Complement-dependent cytotoxicity assays (CDC)

With the ability to deliver bulk scales of consistently-performing human, rabbit and guinea pig complement, we can spare your teams the hassle of doing the preparation, maximizing efficiency, productivity, and consistency.

Frequently asked questions

Should I use human, rabbit, or guinea pig complement for my application?

Work backwards from the readout. Complement regulators are host-specific, so the complement source is part of the assay method, not a preference.

  • Antibody-depleted human complement for the hSBA (serogroup B meningococcus and gonococcus; correlate hSBA ≥ 1:4). Neisseria recruits human factor H, which rabbit and guinea pig factor H cannot replace, and the donor antibodies in native human serum would kill the target on their own.
  • Baby rabbit complement for the rSBA (serogroups A, C, W and Y; correlate rSBA ≥ 1:8) and for pneumococcal OPA/MOPA, which was standardized on it.
  • Adult rabbit complement for complement-dependent cytotoxicity and HLA crossmatching, the classical cell-lysis source.
  • Guinea pig complement where potency per volume is the point: CH50 titration, complement fixation and the vibriocidal assay.

When the model animal's own cascade is the readout, use matched-species complement. Mouse, rat, pig, canine, cynomolgus, goat and hamster complement are available on request through our custom quote form.

For what the research literature actually uses, by pathogen and assay, see which complement source for which assay.

Is complement activity affected by the antibody removal process?

The antibody removal process can result in decreased complement potency in hemolytic titer assays, however, we have optimized our process to limit the extent of this decrease. Each lot of complement is tested using the complement hemolytic titer assay at 50% dilution to confirm adequate functional activity.

How does freezing and thawing affect complement activity?

Multiple freeze-thaw cycles will result in reduced complement potency, so we offer a variety of pack sizes to satisfy applications ranging from small scale assay development experiments to large scale clinical studies. We recommend limiting the number of freeze-thaw cycles and sub-aliquot whenever possible in order to extend the shelf life of all of our complement products.

View all FAQs

8 peer-reviewed papers that used a product from this category, newest first.

All publications
  1. 2026Chanda et al. (2026). bioRxiv (Cold Spring Harbor Laboratory).

    An mRNA–Lipid Nanoparticle Platform Encoding the Conserved Outer Membrane Protein BamA Elicits Broadly Cross-Reactive Systemic and Mucosal Antibodies Against Antimicrobial-Resistant Neisseria gonorrhoeae

    Where the paper cites Pel-Freez

    …362 Ng WHO X (1×10³ CFU in 40 µL HBSS) were added to wells containing diluted test sera 363 and incubated for 15 min at 37°C. Subsequently, 10 µL of either IgG/IgM-depleted normal human serum (NHS; Pel-Freeze Biologicals; Cat. # 34010-10, Lot 34943) or heat- inactivated NHS (HI-NHS; Cat. #34020-10, Lot 13844) was added as a 10% (v/v) complement source, and reactions were incubated for 1 h at 37°C. A single lot of…

  2. 2026Ali et al. (2026). International Journal of Infectious Diseases.

    Do the protein-based meningococcal group B vaccines, 4CMenB and MenB-fHbp, elicit serum bactericidal antibody against meningococcal serogroup X clonal complex 181?

    Where the paper cites Pel-Freez

    …growth CHBA plate after a 4-h incubation. A volume of 10 µL of the bacterial suspension was added to each well of the microtiter plate. A volume of 10 µL of “active” antibody depleted human complement (Pel-Freeze, Inc., Brown Deer, WI) was added to all wells except the sample control wells for viable cfu and sample non-complement mediated lysis control, to which heat-inactivated antibody depleted human complement…

  3. 2025Rosen et al. (2025). International Journal of Infectious Diseases.

    Divergent humoral immune signatures in response to Klebsiella pneumoniae bacteremia

    Where the paper cites Pel-Freez

    …combined with 20 µl of heat-inactivated human serum (inactivated at 56°C for 30 minutes) in 96-well U-bottom plates and incubated shaking at 37°C for 1 h. Subsequently, 10 µl of baby rabbit complement (Pel-Freez Biologics) was added to a final concentration of 10%, and plates were incubated shaking for 1 h at 37°C. All samples were tested in triplicate. Controls included bacteria alone, bacteria with serum only,…

  4. 2025Buisman et al. (2025). npj Vaccines.

    Immunogenicity of primary and booster MenACWY-TT vaccination in older adults and the importance of IgM

    Where the paper cites Pel-Freez

    …Frailty Indicator self-report questionnaire35. Serological analysis Functional MenACWY-specific antibody titers were determined using the serum bactericidal assay with baby rabbit complement (rSBA) (Pelfreez, lot: 21044-C) as described previously15,36. Target strains included MenA (strain 3125), MenC (strain C11), MenW (strain MP01240070), and MenY (strain S-1975). rSBA titers were expressed as the reciprocal…

  5. 2025Fegan et al. (2025). npj Vaccines.

    Rational selection of TbpB variants yields a bivalent vaccine with broad coverage against Neisseria gonorrhoeae

    Where the paper cites Pel-Freez

    …allow opsonization, ~500 CFUs were incubated with various concentrations (1:20, 1:40, 1:80, 1:200, 1:400) of serum for 20 min, followed by the addition of 12% pooled human complement depleted of IgG/IgM (Pel Freez, cat. 34010, Lot 22344) and incubated for 60 min at 37 °C with 5% CO 2 . The highest dilution at which 50% killing was observed relative to no antibody control in 60 min was reported as the SBA titer.…

  6. 2024Reveille et al. (2024). Vaccine.

    Development and validation of a standardized human complement serum bactericidal activity assay to measure functional antibody responses to Neisseria gonorrhoeae

    Where the paper cites Pel-Freez

    …strain lacking pora expression and expressing a hybridized porb (och) [18 ]. see table s3 for a complete description of pc reagents. 3.4 intrinsic sba growth assay igg/igm-depleted human complement (c′) pooled serum (pel-freez validation lot #03642) was screened for endogenous killing activity against ng strains f62, ms11, and fa1090 as previously described [19 ] with modifications. briefly, sialylated or non-sial…

Need a custom product?

We can help. Because all of our products are manufactured according to our ISO 9001-certified quality standards, we have complete control of every step. Let us know how we can customize any product to meet your specific project needs.